Analyzing Maternal Acetaminophen and Neurodevelopment in Large Cohorts

The relationship between maternal acetaminophen and neurodevelopment has been a subject of intense scientific and public debate. Acetaminophen, widely known as paracetamol in India, is frequently used for managing pain and fever during pregnancy. Recent evidence from a massive Taiwanese cohort study involving over 2 million singleton births provides crucial insights into whether this drug influences the risk of Attention-Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD).

Initially, researchers observed a positive correlation between prenatal acetaminophen prescriptions and neurodevelopmental disorders in the general population. Specifically, higher doses and more frequent use appeared to correspond with increased risks. However, the study's primary contribution lies in its sibling-matched analysis. By comparing siblings within the same family, researchers could better control for shared genetic and environmental factors that might otherwise confound the results.

Remarkably, the sibling-matched analyses found that the associations between prenatal acetaminophen exposure and ADHD or ASD were null. These results suggest that earlier observed risks likely stemmed from unaddressed familial confounding factors rather than the medication itself. Consequently, while the study highlights the complexity of such associations, it reinforces the overall safety profile of paracetamol when used as directed under medical supervision.

Evidence on Maternal Acetaminophen and Neurodevelopment

For clinicians in India, these findings are particularly relevant given the high prevalence of paracetamol use among expectant mothers. Furthermore, the study suggests that the \"confounding by indication\" is a significant consideration. This occurs when the underlying reason for taking the medicine, such as a severe fever or infection, is the actual risk factor rather than the drug. Therefore, while practitioners should continue to advise the lowest effective dose, the data provides reassurance that appropriate use is unlikely to be a direct cause of neurodevelopmental conditions.

Frequently Asked Questions

Does taking paracetamol during pregnancy cause autism?

Current high-quality evidence, including large sibling-matched studies, indicates that there is no causal link between prenatal paracetamol use and the development of autism spectrum disorders.

Should pregnant women avoid acetaminophen for pain relief?

No, acetaminophen remains the first-line recommendation for pain and fever in pregnancy. Untreated maternal fever can itself pose risks to the fetus, so the medication should be used when clinically indicated at the lowest effective dose.

What did the Taiwan study conclude about ADHD risk?

While an initial link was found in the general cohort, the sibling-matched analysis showed no significant association between maternal acetaminophen and ADHD. This suggests familial and genetic factors play a larger role than the drug exposure.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Lee PC et al. Maternal Acetaminophen Use and Child Neurodevelopment. JAMA Pediatr. 2026 Mar 09. doi: 10.1001/jamapediatrics.2026.0071. PMID: 41801232.

D'Antonio F et al. Prenatal paracetamol exposure and child neurodevelopment: a systematic review and meta-analysis. Lancet Obstet Gynaecol Women's Health. 2026. doi:10.1016/S3050-5038(25)00211-0.

Ahlqvist VH et al. Acetaminophen Use During Pregnancy and Children's Risk of Autism, ADHD, and Intellectual Disability. JAMA. 2024;331(14):1205-1214.